We conclude that the 6xTg mouse model of Alzheimer's disease is an animal model suitable for studying the impact of amyloid-β and tau pathology observed in Alzheimer’s disease as well as the neurobiological mechanisms underlying the Alzheimer’s disease-relevant impairment in cognitive and non-cognitive behaviors. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.